Free Trial
→ Washington Is Broke—Could YOUR Savings Be Next? (From Priority Gold) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$107.29
-1.7%		$118.62
$100.85
▼
$212.00
$3.55B1.45599,105 shs116,577 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.49
+0.0%		$124.11
$62.00
▼
$126.79
$4.30B0.58771,930 shs76,711 shs
LivaNova PLC stock logo
LIVN
LivaNova
$75.81
-0.8%		$79.21
$48.82
▼
$85.76
$4.18B0.87744,586 shs55,522 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.58
+0.4%		$19.57
$12.26
▼
$29.65
$1.15B1.662.10 million shs334,173 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-1.16%-3.12%-11.36%-12.79%-37.88%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.12%+0.21%+0.17%+37.91%+20.35%
LivaNova PLC stock logo
LIVN
LivaNova
+1.81%-1.01%-6.70%-8.55%+43.21%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+0.12%+0.61%-16.98%+7.06%+12.30%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$107.29
-1.7%		$118.62
$100.85
▼
$212.00
$3.55B1.45599,105 shs116,577 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.49
+0.0%		$124.11
$62.00
▼
$126.79
$4.30B0.58771,930 shs76,711 shs
LivaNova PLC stock logo
LIVN
LivaNova
$75.81
-0.8%		$79.21
$48.82
▼
$85.76
$4.18B0.87744,586 shs55,522 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.58
+0.4%		$19.57
$12.26
▼
$29.65
$1.15B1.662.10 million shs334,173 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-1.16%-3.12%-11.36%-12.79%-37.88%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.12%+0.21%+0.17%+37.91%+20.35%
LivaNova PLC stock logo
LIVN
LivaNova
+1.81%-1.01%-6.70%-8.55%+43.21%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+0.12%+0.61%-16.98%+7.06%+12.30%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$178.7966.64% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-13.15% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.55
Moderate Buy$84.1310.97% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.48
Hold$29.1375.67% Upside

Current Analyst Ratings Breakdown

Latest TNDM, ITGR, LIVN, and IRTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$168.00 ➝ $150.00
10/5/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$192.00 ➝ $194.00
9/30/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$24.00 ➝ $20.00
9/24/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$31.00 ➝ $28.00
9/14/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/14/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/8/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $90.00
8/21/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
(Data available from 10/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$825.34M4.29N/AN/A$4.74 per share22.64
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.32$10.37 per share12.20$49.85 per share2.54
LivaNova PLC stock logo
LIVN
LivaNova
$1.47B2.84$4.88 per share15.52$21.98 per share3.45
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.01B1.14N/AN/A$2.29 per share7.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.43N/A73.99N/A-1.69%10.11%1.53%10/29/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.5618.852.406.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3822.4418.22N/A12.82%16.35%7.76%11/4/2026 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$0.93N/A184.26N/A-6.08%-45.97%-6.23%11/5/2026 (Estimated)

Latest TNDM, ITGR, LIVN, and IRTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$0.0230N/AN/AN/A$222.25 millionN/A
10/22/2026Q3 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.68N/AN/AN/A$456.91 millionN/A
8/6/2026Q2 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.04$0.58+$0.62-$0.01$219.30 million$224.17 million
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/6/2026Q2 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.3207-$0.31+$0.0107-$0.31$254.99 million$254.56 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.50
3.86
3.74
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.62
3.18
2.65

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.96 million32.64 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00034.00 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50069.58 million68.12 millionOptionable

Recent News About These Companies

Tandem Diabetes Care stock gains 2.36 percent before Q3 results
October 5 at 11:36 PM  |  ad-hoc-news.deA
Tandem Diabetes Care (TNDM) Receives a Buy from RBC Capital
October 5 at 8:33 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/4947000/tandem-diabetes-care-tndm-receives-a-buy-from-rbc-capital/
Citigroup Has Lowered Expectations for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price
October 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31076669
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
October 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-care-announce-third-200500857.html
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
October 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-care-tndm-7-012256615.html
Citigroup Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price
September 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-citigroup-issues-pessimistic-forecast-for-tandem-diabetes-care-nasdaq-tndm-stock-price-2026-09-30/
Financial Contrast: IRIDEX (NASDAQ:IRIX) and Tandem Diabetes Care (NASDAQ:TNDM)
September 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31068630
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries
September 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-expands-insulin-delivery-094359106.html
Tandem Diabetes Care, Inc. Announces Tandem Mobi Automated Insulin Delivery System Is Now Available in Twelve International Markets
September 28, 2026  |  marketscreener.comM
Tandem Diabetes expands Mobi insulin system overseas
September 28, 2026  |  grafa.comG
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets
September 28, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260928831177/en/tandem-mobi-automated-insulin-delivery-system-now-available-in-twelve-international-markets/
Tandem Diabetes Care(TNDM)获机构维持买入评级，目标价下调至28美元
September 26, 2026  |  eeo.com.cnE
Tandem Diabetes Care (NASDAQ:TNDM) Stock Falls 6.7% After Analyst Downgrade
September 26, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31051841
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Target Cut by Truist Financial
September 26, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31051517
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.7% After Analyst Downgrade
September 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-stock-price-down-67-after-analyst-downgrade-2026-09-24/
Tandem Diabetes Care (NASDAQ:TNDM) Given New $28.00 Price Target at Truist Financial
September 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-tandem-diabetes-care-nasdaq-tndm-given-new-2800-price-target-at-truist-financial-2026-09-24/
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating
September 24, 2026  |  marketscreener.comM
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return?
September 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tandem-diabetes-care-tndm-undervalued-091010599.html
Engineers Gate Manager LP Makes New Investment in Tandem Diabetes Care, Inc. $TNDM
September 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-engineers-gate-manager-lp-makes-new-investment-in-tandem-diabetes-care-inc-tndm-2026-09-20/
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Brokerages
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-tandem-diabetes-care-inc-nasdaq-tndm-receives-consensus-rating-of-hold-from-brokerages-2026-09-18/
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
September 17, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2991045/tandem-diabetes-care-tndm-soars-7-7-is-further-upside-left-in-the-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|daily_price_change_5%-2991045

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$107.29 -1.80 (-1.65%)
As of 11:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Integer stock logo

Integer NYSE:ITGR

$126.48 +0.04 (+0.03%)
As of 11:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$75.81 -0.62 (-0.81%)
As of 11:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$16.58 +0.06 (+0.38%)
As of 11:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas